Keep up with what's happening in the crypto world in real-time.
All Filters (1)
Injective Protocol's native crypto, INJ, has been on an impressive winning streak over the past seven days, outshining every other cryptocurrency in the top 100. With an incredible surge of over 20% in just a week, INJ has caught the attention of the crypto world, with many wondering what could be fueling such an impressive rise.
These are the five altcoins that had the most positive performance from the crypto market last week.
Injective Protocol (INJ/USD) price has defied gravity in the past few days. The token continued soaring and reached a high of $6.05, the highest point since April 2022. It has been one of the top-performing cryptocurrencies this year, having jumped by ~367% from its lowest.
As the world witnesses an unparalleled AI explosion, Injective Protocol (INJ) has been soaring on the wings of cutting-edge innovation and expansion, boasting a remarkable price surge of over 300% year-to-date (YTD). Attaining a 90-day peak of $5.
Injective, a decentralized exchange and layer-2 protocol has announced the release of Cascade, the first-ever Solana Sealevel Virtual Machine (SVM) rollup for the inter-Blockchain Communication (IBC) ecosystem supported by Cosmos.
Injective had recently integrated with Wormhole which made it the first chain in the Cosmos ecosystem to support Solana assets.
Eclipse and Injective have partnered to launch Cascade: a rollup chain that is compatible with Solana-based applications.
The new testnet is one of the few networks that uses Solana's Sea Level Virtual Machine (SVM).
Astroport, which claims to be one of the most “popular” decentralized exchanges, launched its beta on the Injective testnet. Injective is described as a fast blockchain built for finance.
Injective, a layer-1 blockchain technology, is funding Cosmos network developers with $150 million. Pantera Capital, Kraken Ventures, Jump Crypto, and Gate Labs support the fund.
Finance-focused blockchain Injective has launched a $150 million ecosystem fund to accelerate interoperable infrastructure and decentralized finance (DeFi) adoption, according to a January 25 press release.
Eric Chen, CEO and co-founder of Injective Labs, and core contributor to Injective, has shared insights with CI about how the FTX contagion is upending investments in DeFi projects and what to expect for the future of digital assets.
To say that 2022 was a “monumental” year for Injective is an “understatement,” the developers claim.
The Injective (INJ) price has broken out from a short-term resistance line after news of a 5 million token burn. The post Injective (INJ) Price Shoots up 15% After 5 Million Tokens Burned appeared first on BeInCrypto.
As Dogecoin gains traction due to the completion of the Elon Musk-Twitter deal, Shiba Inu which is in close connection with DOGE has also gained some momentum. SHIB had a bullish momentum hitting a target of $0.00001275 just a day before setting back from its upward price action.
A crypto strategist known for his timely altcoin calls says traders looking to suddenly flip bullish on meme token Shiba Inu (SHIB) at current levels should exercise caution. Pseudonymous trader Altcoin Sherpa tells his 185,700 Twitter followers that Shiba Inu might be losing some steam after failing to break key resistance levels.
Widely followed crypto analyst Michaël van de Poppe says rallies are imminent for Ethereum (ETH) challenger Avalanche (AVAX) and decentralized derivatives exchange protocol Injective (INJ).
The year 2022 has experienced an extended pump and dump trade especially from May. Today the market appears a bit greener as Bitcoin has gained 0.46% while Ethereum has surged by 0.63% in the last 24hrs. The same is followed by other altcoins like BNB, XRP, Cardano among others.
A popular crypto strategist is bearish on Fantom (FTM) and two other altcoins while warning of a potential Bitcoin (BTC) crash. Pseudonymous analyst Altcoin Sherpa tells his 184,900 Twitter followers that smart contract-enabled blockchain Fantom is collapsing.
A popular crypto strategist and trader is predicting more rallies to come for two low-cap altcoins that have recently shown strength. The pseudonymous analyst known in the industry as Altcoin Sherpa tells his 184,400 Twitter followers that decentralized derivatives exchange Injective Protocol (INJ) is the “gift that keeps on giving.” “This entire area ($2.
Crypto exchange Coinbase has announced support for three Ethereum (ETH)-based altcoins as the digital asset market faces ongoing downward pressure.
Injective Protocol (INJ) has had a tough time seeing its price shed over 90% from its all-time high of $24.8 against tether (USDT). Despite recently seeing a huge pullback in the crypto market, Injective Protocol (INJ) continues to show immense strength, racking up double-digit gains.
Injective, a blockchain built for finance, recently announced a new $40 million funding round led by Jump Crypto. BH Digital, the crypto arm of famed hedge fund manager Alan Howard, has also joined the investment round.
Projects including Injective Labs, Ansible Labs, Lysto, Ultimate Money, Join Creator DAO, and Pinata Cloud continue with successful funding rounds.
